NCT06789471View on ClinicalTrials.gov

The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

October 1, 2024

Conditions
Overweight and ObesityMetabolic Cardiovascular SyndromeSchizophrenia, Disorganized
Interventions
DIETARY_SUPPLEMENT

psyllium husk

Psyllium husk, derived from the seeds' husks of the Plantago ovata plant, is a plant-based fiber supplement.

Trial Locations (1)

403

Taichung Hospital, Taichung

All Listed Sponsors
lead

Ru-Shin Zhang

OTHER

NCT06789471 - The Effects of Psyllium Seed on Body Weight and Metabolic Syndrome Indicators in Patients with Schizophrenia | Biotech Hunter | Biotech Hunter